Antares Pharma CEO Robert Apple's 2020 pay rises 7% to $3.8M
Antares Pharma reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Antares Pharma reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, four executives at Antares Pharma received on average a compensation package of $1.7M, a 5% decrease compared to previous year.
Average pay of disclosed executives at Antares Pharma
Robert F. Apple, Chief Executive Officer, received $3.8M in total, which increased by 7% compared to 2019. 44% of Apple's compensation, or $1.7M, was in stock awards. Apple also received $397K in non-equity incentive plan, $1.1M in option awards, $592K in salary, as well as $15K in other compensation.
For fiscal year 2020, the median employee pay was $142,773 at Antares Pharma. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 26 to one.
Fred M. Powell, Chief Financial Officer, received a compensation package of $1.5M, which increased by 10% compared to previous year. 35% of the compensation package, or $540K, was in stock awards.
Peter J. Graham, General Counsel, earned $1.5M in 2020, a 13% increase compared to previous year.
James P. Tursi, Chief Medical Officer, received $140K in 2020, which decreases by 87% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 27, 2021.